<DOC>
	<DOCNO>NCT01201707</DOCNO>
	<brief_summary>The study do determine venous angioplasty effective treatment chronic cerebrospinal venous insufficiency ( CCSVI ) . In condition , area narrow blockage present internal jugular azygos vein ( vein drain blood central nervous system ) blockages may associate symptom classically attribute MS . Therefore , angioplasty may help improve symptom associate CCSVI multiple sclerosis ( MS ) . In study , investigator evaluate effectiveness angioplasty treatment CCSVI compare two outcome two group patient : one group CCSVI diagnose venogram treat angioplasty one group CCSVI diagnose venogram treat . The patient enrol study , neurologist evaluate patient procedure , know whether treated angioplasty .</brief_summary>
	<brief_title>Evaluation Angioplasty Treatment Chronic Cerebrospinal Venous Insufficiency ( CCSVI ) Multiple Sclerosis</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Venous Insufficiency</mesh_term>
	<criteria>Patients willing comply protocol requirement contact telephone Patients 1860 year age Patients clinically definite multiple sclerosis Polman criteria Patients history MS define EDSS 36 . Patients significant stenosis internal jugular azygos vein basis magnetic resonance venography Doppler ultrasound . Patients renal insufficiency base estimate GFR &lt; 45 Patients know severe allergy iodine gadoliniumbased contrast agent adequately premedicated Patients know allergy nickel Patients pregnant Patients contraindication anticoagulation antiplatelet medication Patients contraindication drug use conscious sedation interventional procedure , include Versed Fentanyl Patients history deep venous thrombosis low extremity Patients occlusion right leave common femoral vein Patients change disease modify drug regimen MS 6 month prior enrollment trial . This would include addition new medication , change dosage medication , removal medication patient 's drug regimen Patients life expectancy &lt; 18 month Patients currently enrol plan enroll investigation conflict followup test confounds data trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Multiple Sclerosis</keyword>
	<keyword>Angioplasty</keyword>
	<keyword>Vein</keyword>
</DOC>